Medicina
Fakultatea
Claude Bernard University Lyon 1
Villeurbanne, FranciaClaude Bernard University Lyon 1-ko ikertzaileekin lankidetzan egindako argitalpenak (75)
2024
-
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Blood
-
Profiling the dysregulated immune response in sepsis: overcoming challenges to achieve the goal of precision medicine
The Lancet Respiratory Medicine, Vol. 12, Núm. 4, pp. 305-322
2023
-
Bintrafusp Alfa Versus Pembrolizumab in Patients With Treatment-Naive, Programmed Death-Ligand 1–High Advanced NSCLC: A Randomized, Open-Label, Phase 3 Trial
Journal of Thoracic Oncology, Vol. 18, Núm. 12, pp. 1731-1742
-
ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
Multiple Sclerosis Journal
-
European Committee for Treatment and Research in Multiple Sclerosis and European Academy of Neurology consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
European Journal of Neurology, Vol. 30, Núm. 8, pp. 2144-2176
-
Extracorporeal Techniques in End-Stage Kidney Disease
Blood Purification
-
Identification of Patients with Early HR+ HER2- Breast Cancer at High Risk of Recurrence
Geburtshilfe und Frauenheilkunde, Vol. 84, Núm. 2, pp. 164-184
-
Predictors of treatment switching in the Big Multiple Sclerosis Data Network
Frontiers in Neurology, Vol. 14
2022
-
An International Registry of Peritoneal Carcinomatosis from Appendiceal Goblet Cell Carcinoma Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy
World Journal of Surgery, Vol. 46, Núm. 6, pp. 1336-1343
-
Autoantibodies against type I IFNs in patients with critical influenza pneumonia
The Journal of experimental medicine, Vol. 219, Núm. 11
-
Clinical research in ovarian cancer: consensus recommendations from the Gynecologic Cancer InterGroup
The Lancet Oncology, Vol. 23, Núm. 8, pp. e374-e384
-
Intravitreal Corticosteroid Implantation in Diabetic Macular Edema: Updated European Consensus Guidance on Monitoring and Managing Intraocular Pressure
Ophthalmology and Therapy
-
Long-term disease control and safety with the anti-CCR4 antibody mogamulizumab: Post-hoc analyses from the MAVORIC trial of patients with previously treated cutaneous T-cell lymphoma
Dermatologic Therapy
-
Partial Hydrolyzed Protein as a Protein Source for Infant Feeding: Do or Don’t?
Nutrients, Vol. 14, Núm. 9
-
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
New England Journal of Medicine, Vol. 386, Núm. 7, pp. 629-639
-
The risk of infections for multiple sclerosis and neuromyelitis optica spectrum disorder disease-modifying treatments: Eighth European Committee for Treatment and Research in Multiple Sclerosis Focused Workshop Review. April 2021
Multiple sclerosis (Houndmills, Basingstoke, England), Vol. 28, Núm. 9, pp. 1424-1456
-
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nature Medicine, Vol. 28, Núm. 2, pp. 325-332
2021
-
COVID-19-associated pulmonary aspergillosis, March-August 2020
Emerging Infectious Diseases, Vol. 27, Núm. 4, pp. 1077-1086
-
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival
International Journal of Cancer, Vol. 148, Núm. 8, pp. 1887-1894
-
Esophagogastric junction morphology and contractile integral on high-resolution manometry in asymptomatic healthy volunteers: An international multicenter study
Neurogastroenterology and Motility, Vol. 33, Núm. 6